1998
DOI: 10.1023/a:1022578303272
|View full text |Cite
|
Sign up to set email alerts
|

Untitled

Abstract: Although women who undergo chemotherapy face limited options for fertility preservation, intensive studies in cryopreservation and in vitro maturation of follicles harbor hope for brighter prospects in the future.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2000
2000
2019
2019

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 44 publications
(3 citation statements)
references
References 77 publications
0
3
0
Order By: Relevance
“…Human isolated primordial follicles do not grow properly in culture. 73,74 Indeed, despite the encouraging results achieved by Hovatta, 75 it has not yet been possible to grow human isolated primordial follicles to the mature oocyte stage. This led us to consider an alternative strategy, which involves grafting isolated ovarian follicles.…”
Section: Isolated Preantral Folliclesmentioning
confidence: 99%
“…Human isolated primordial follicles do not grow properly in culture. 73,74 Indeed, despite the encouraging results achieved by Hovatta, 75 it has not yet been possible to grow human isolated primordial follicles to the mature oocyte stage. This led us to consider an alternative strategy, which involves grafting isolated ovarian follicles.…”
Section: Isolated Preantral Folliclesmentioning
confidence: 99%
“…Advancements in cancer treatment continue to improve survival and cure rates in women of reproductive age. Many, however, will struggle with ovarian failure and premature menopause as a consequence of potentially gonadotoxic chemotherapy and radiation [ 1 ]. Among the options currently available for fertility preservation in these patients is cryopreservation and future auto-transplantation of ovarian cortical tissue containing immature follicles [ 2 , 3 ].…”
Section: Introductionmentioning
confidence: 99%
“…To date, various efforts have been made to preserve ovarian function and fertility, for example, administration of gonadotropinreleasing hormone agonist prior to the initiation of chemotherapy, cryopreservation of embryos, mature oocytes, or ovarian tissue (Pereira et al, 2017). Although means of ovarian protections (Abir, Fisch, Raz, Nitke, & Ben-Rafael, 1998) were attempted to prevent or decrease the loss of fertility before the chemotherapy or radiotherapy Eun Cho and Yoon Young Kim contributed equally to this work. (Fisch & Abir, 2018), current treatments are still highly toxic to gonads such as ovary and testis.…”
mentioning
confidence: 99%